7575.T Stock - Japan Lifeline Co., Ltd.
Unlock GoAI Insights for 7575.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $56.61B | $51.38B | $51.75B | $51.47B | $51.29B |
| Gross Profit | $33.42B | $30.99B | $29.89B | $28.84B | $28.66B |
| Gross Margin | 59.0% | 60.3% | 57.8% | 56.0% | 55.9% |
| Operating Income | $12.32B | $10.89B | $10.84B | $9.97B | $10.37B |
| Net Income | $9.32B | $7.51B | $6.89B | $7.48B | $2.00B |
| Net Margin | 16.5% | 14.6% | 13.3% | 14.5% | 3.9% |
| EPS | $131.43 | $98.72 | $88.22 | $93.12 | $24.90 |
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
7575.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Jan 30, 2026 | — | — | — | — |
Q4 2025 | Oct 29, 2025 | — | $35.23 | — | — |
Q3 2025 | Jul 31, 2025 | — | $32.84 | — | — |
Q2 2025 | May 7, 2025 | — | $32.04 | — | — |
Q1 2025 | Jan 31, 2025 | — | $37.60 | — | — |
Q4 2024 | Oct 31, 2024 | — | $29.89 | — | — |
Q3 2024 | Jul 31, 2024 | — | $31.94 | — | — |
Q2 2024 | May 1, 2024 | — | $17.89 | — | — |
Q1 2024 | Feb 2, 2024 | — | $28.32 | — | — |
Q4 2023 | Nov 6, 2023 | — | $22.31 | — | — |
Q3 2023 | Aug 2, 2023 | — | $30.02 | — | — |
Q2 2023 | May 10, 2023 | $22.38 | $29.77 | +33.0% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $29.01 | $11.15 | -61.6% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $16.48 | $22.54 | +36.8% | ✓ BEAT |
Q3 2022 | Jul 29, 2022 | $21.27 | $24.73 | +16.3% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $26.28 | $24.45 | -7.0% | ✗ MISS |
Q1 2022 | Jan 28, 2022 | $30.90 | $24.01 | -22.3% | ✗ MISS |
Q4 2021 | Nov 1, 2021 | $28.90 | $23.49 | -18.7% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $19.49 | $21.18 | +8.7% | ✓ BEAT |
Latest News
Frequently Asked Questions about 7575.T
What is 7575.T's current stock price?
What is the analyst price target for 7575.T?
What sector is Japan Lifeline Co., Ltd. in?
What is 7575.T's market cap?
Does 7575.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 7575.T for comparison